Likely a lot more upside now considering US slapping tariffs on most SEA and ASEAN countries. New plant and capacity helps with new order take up... Hope Dpharma Commercial team has been aggressively lobbying in the last months to capitalise this opportunity

股是不错的好股，只是爆发力与持续力不强。目前看来这股属于长期型的。

毕竟马来西亚有医疗津贴，不过医药行业的价值肯定是一直越起越贵，人口也是会越来越多。

如果它派发的股息能再高些肯定会吸引更多投资者。

目前的情况想投资就是只能低收等看未来有天如何爆发。